RF Tightening After Filler: What to Tell Your Seoul Doctor and When to Wait

The short answer: the filler record comes before the calendar

If a friend asked, ‘How many weeks after filler can I have Thermage?’ I would not give one number without the treatment record. Hyaluronic-acid gel, calcium-hydroxylapatite, poly-L-lactic acid, polymethylmethacrylate and other injectable materials do not behave as one category. Product, amount, tissue plane, facial zone, date, current swelling and the planned RF device all change the decision.

Thermage's current U.S. safety information explicitly says Solta Medical has not studied use of the system over skin fillers in the lips, cheeks, facial wrinkles and folds. That is not proof that every combination causes harm, but it rules out presenting Thermage-over-filler as universally established or giving a manufacturer-backed waiting interval that does not exist.

A Seoul physician may treat a different zone, select another plan, stage procedures, wait for examination and recovery, or recommend no RF. Bring the exact filler name and date even if the injection was performed years ago: published histology has found hyaluronic-acid filler persisting much longer than its visible cosmetic effect in some people.

What to bring: ‘I had filler’ is not enough detail

Ask the previous clinic for the brand, variant, material, lot, amount, injection date and treated areas. If available, include the intended tissue plane, technique, any hyaluronidase treatment and unfiltered photographs before and after injection. A receipt that says only ‘filler’ cannot tell the next doctor what remains in which layer.

Tell the RF clinician about lumps, tenderness, recurrent swelling, color change, infection, dental work, immune or inflammatory reactions and every other energy treatment in the area. Active inflammation or an unexplained nodule deserves assessment before heat is added. The U.S. FDA also advises patients to read the specific filler labeling and discuss injection sites and product-specific risks with a licensed, trained health professional.

The actual SKINVIVE package shown below is one clinic-owned product example, not a stand-in for every filler. Even within the hyaluronic-acid family, concentration, cross-linking, companion ingredients, authorized area and placement can differ. A photograph helps identify a box; it cannot establish where or how your own product was injected.

What the combination evidence actually shows

A 2023 clinicohistological study enrolled 14 volunteers and placed hyaluronic-acid filler at four abdominal sites. Monopolar RF was applied immediately, 14 days or 28 days after injection at three sites. Histologic HA grades decreased in five participants after immediate RF and in one participant in each of the 14-day and 28-day groups. The authors concluded that RF after HA injection may affect filler integrity, particularly when performed the same day.

That study is useful but narrow. It tested abdominal tissue, one HA preparation and one protocol in a small group; it did not test every facial plane, filler family, Thermage FLX setting or XERF mode. Its 14- and 28-day observations should not be converted into a guaranteed safe interval for an individual face.

A 2019 review and expert panel on HA filler with laser, RF and IPL said the evidence was limited and consisted mainly of small, nonrandomized studies. For same-day combination, the panel recommended energy treatment before HA injection and avoiding manipulation after injection. That is expert guidance rather than a universal product-label instruction, and Thermage's own filler precaution still deserves priority for a Thermage-specific plan.

Same day, two weeks or one month? Why no single answer fits

The available sources do not establish one waiting period that covers every filler, RF platform, depth, energy, facial area and medical history. A calendar rule also cannot show whether the filler area is still swollen, whether the intended RF field overlaps it or whether a new contour concern is caused by filler, edema, laxity or natural anatomy.

If both procedures are being considered in one trip, ask why they need to happen in the same visit. A physician should explain the sequence, treated zones, tissue goals, evidence and recovery plan. The safer answer may be to complete RF first and inject later, to separate visits for reassessment, or to avoid combining them—but those choices require examination and the exact products involved.

Do not let a flight, event or expiring package turn a limited-evidence sequence into an emergency. Leave room for visible swelling or redness to settle and for an in-person review. If the previous product or injection plane cannot be confirmed, uncertainty itself is information the doctor should use.

• Name the exact filler material, brand, amount, area and date.
• Map whether the proposed RF field overlaps the injected zone.
• Ask which device, tip or mode, settings and passes are planned.
• Separate manufacturer labeling from small studies and expert opinion.
• Confirm who reviews unexpected swelling, pain or contour change.

XERF is another RF plan—not evidence for a universal shortcut

Cynosure describes XERF as a monopolar RF platform combining 6.78 MHz and 2 MHz, with three depth settings, ten intensity levels, impedance feedback and cryogen cooling. Those controls may help a qualified clinician individualize treatment, but XERF's public U.S. intended-use statement does not provide a filler-specific sequence or waiting interval. Device specifications cannot fill that evidence gap.

The FDA recall database also continues to list an open Class II recall for specific XERF EFFECTOR 60 catalog and serial or lot numbers manufactured in 2025. It does not apply to every XERF unit. A clinic should verify the exact equipment and treatment tip against the current recall notice before use, independently of the filler discussion.

For either XERF or Thermage, ask the doctor to mark treated and excluded zones and explain why the planned thermal field is appropriate around the known filler location. Shot count alone is not a treatment depth, a filler-safety measure or a comparable dose between machines.

Recovery, warning signs and a calmer Seoul-trip plan

RF can cause temporary warmth, redness, swelling, tenderness or altered sensation. Thermage's official safety information also lists uncommon possibilities including blisters or burns, scabbing, scarring, surface irregularities, lumps or nodules and pigment change. A new injectable can separately cause bruising, pain, itching, infection, inflammation or nodules, so overlapping recovery can make the source of a symptom harder to interpret.

Unintentional filler injection into a blood vessel is an uncommon medical emergency that can cause tissue injury, visual impairment, blindness or stroke. Seek immediate medical attention for unusual or escalating pain, white, gray or blue skin, vision change, sudden weakness, facial droop, trouble speaking or another stroke-like symptom during or shortly after injection. After either procedure, promptly contact a clinician for blistering, spreading redness, drainage, fever, worsening swelling or a firm new lump.

Before leaving Seoul, keep an English record of the filler and RF device, treated zones, dates and written aftercare. Confirm a local urgent-contact route and what follow-up is available after you fly home. A careful plan should make the uncertainty visible instead of presenting one timetable as universally applicable.